Stifel reiterates Buy rating on Align Technology stock ahead of earnings

Stifel maintained its Buy rating and $275 price target for Align Technology (ALGN), citing positive survey results ahead of its Q2 earnings and strong financial health, with the stock trading at $190.24 and significant upside potential. The firm anticipates potential upward revisions to 2025/2026 estimates driven by favorable FX and VAT dynamics, emphasizing that accelerated case volume and revenue growth in 2026 are crucial for reaching long-range targets and multiple expansion. This follows Align's Q1 2025 earnings beat, a new $1 billion stock buyback authorization, and key corporate governance changes, including the adoption of a simple majority vote for significant decisions.

Analysis

Stifel has maintained its Buy rating and a $275.00 price target on Align Technology (ALGN), signaling significant potential upside from its current price of $190.24. This optimism is underpinned by positive survey results ahead of the Q2 earnings report and the company's strong financial health, which includes a robust 70% gross profit margin and a 12% return on invested capital. The firm anticipates potential upward revisions to 2025 and 2026 Wall Street estimates, driven by favorable foreign exchange and VAT dynamics. This positive outlook is further supported by Align's recent performance, including a Q1 2025 earnings beat with an EPS of $2.13 and the announcement of a new $1 billion stock buyback program. However, Stifel's analysis clearly states that for the stock to approach the price target, Align must demonstrate accelerated case volume and achieve high single-digit revenue growth in 2026, aligning with its long-range plan of 5-15% growth. Corporate governance has also been updated, with shareholders approving a move to simple majority voting, a potentially shareholder-friendly change.

Key Decisions for Investors

• Given the strong analyst endorsement, recent earnings beat, and a new $1 billion share repurchase program, investors could view the current share price as an attractive entry point with considerable upside to the $275 target.
• Investors should closely monitor forward guidance in the upcoming Q2 earnings report on July 30, paying specific attention to commentary on case volume and revenue growth trends, which are critical catalysts for the stock's multiple expansion.
• The investment thesis is contingent on Align achieving accelerated growth in 2026; failure to demonstrate a clear path towards its 5-15% long-range growth target represents the primary risk to the bullish outlook.